User experienced scarring from microneedling at fast speed and paused treatment for 3-4 weeks to recover. Advice given includes waiting a full month for recovery to avoid scars.
The conversation discusses using topical finasteride and minoxidil for hair loss, focusing on the crown and mid-scalp areas. The user is optimistic about seeing results in 3 to 6 months.
A potential new hair loss treatment, HMI-115, and the possibility of discontinuing finasteride in favor of it. The conversation also includes discussion about other benefits of using finasteride.
The user has been on finasteride for 5 months and noticed their hair becoming wispy/frizzy, suspecting minoxidil might have also contributed to the change. They are distressed by the change in their hair's appearance.
Discussion on hair loss treatments, focusing on Breezula, with mentions of Minoxidil, finasteride, RU58841, Pyrilutamide, GT20029, and PP405. Breezula's effectiveness is uncertain, with some trials showing minimal regrowth.
The conversation is about different treatments for hair loss, including minoxidil, finasteride, RU58841, and dermarolling. The conclusion is that RU58841 and dermarolling have shown efficacy in treating hair loss through different pathways.
A user who was able to regrow hair loss with 1mg of finasteride daily over 3 years, the effectiveness of finasteride for different races, and potential side effects associated with taking finasteride.
A user's progress pictures with Finasteride, showing positive results in 7 months; other users suggested additional treatments like biotin and nizoral shampoo, as well as changing to Dutasteride, while another mentioned it could take up to a year for further gains.
A user shared their experience with hair loss treatments, including finasteride, minoxidil, and RU58841, which improved their hair from a diffuse NW3 to a solid NW2 - 2.5. They noticed significant changes in how people treated them after regrowing their hair, suggesting that attractiveness can greatly impact social interactions and opportunities.
A user experienced accelerated hairline recession after adding dutasteride to their regimen of topical finasteride and minoxidil, despite reduced hair shedding. They were informed that ELISA testing for DHT levels can be highly inaccurate.
Switching from finasteride to dutasteride and back to finasteride, with mixed results on hair loss and side effects like oily skin and acne. Some users experienced regrowth with oral minoxidil, while others noted differences in effectiveness and side effects between the two medications.
The user is experiencing continued hair loss despite using finasteride, dutasteride, and minoxidil, and is advised to improve diet, check for deficiencies, and consider other treatments like microneedling. Suggestions include sticking with the current regimen, considering a hair transplant, or accepting hair loss and shaving.
Researching the effectiveness of the hair loss treatment Pyril in comparison to other treatments such as Minoxidil, Finasteride, and RU58841. Replies suggest that users often fail to provide updates on their experience with Pyril.
The user is concerned about potential hair thinning after getting a buzzcut and shares photos for comparison. A suggestion is made to consult a dermatologist for a proper diagnosis.
The conversation discusses the use of Finastopic, a carrier for finasteride solutions by Isdin, and compares it to a standard propylene glycol (PG) solution. The user was prescribed a 1% finasteride solution using Finastopic and has been using a self-compounded 0.025% topical finasteride with minoxidil.
The user is discussing hair regrowth after 3.5 months of using finasteride, questioning if the new growth is baby hairs. They compare photos from December to the present to assess progress.
The user is experiencing hair shedding despite using finasteride, minoxidil, and microneedling, and is concerned about the non-linear progress. Other users share similar experiences, suggesting shedding is normal and cyclical, with some recommending less frequent microneedling.
High cost of studying 3α-Hydroxysteroid dehydrogenase in hair loss led to suggestions of crowdfunding for research. Users discussed using Procyanidin B2/melatonin topical treatment and tracking funds with blockchain.
A 20 year old male's experience with hair loss treatments, including finasteride, minoxidil, microneedling, nizoral shampoo, dutasteride, alfatradiol, stemoxydine and RU58841, over the course of two years. The user reported losing ground overall but their hair becoming curly, which helped hide more scalp.
The user has been using finasteride, minoxidil, and other treatments for nearly a year without progress in hair regrowth, feeling frustrated and depressed. Suggestions include trying dutasteride, considering a scalp biopsy, and acknowledging that stopping hair loss might be the only achievable outcome.
A user's hair loss progress after 4 months of using a topical fin and min mix, with responses from other users about their experience with the same treatments.
The conversation discusses the use of 5-alpha-reductase inhibitors like finasteride and dutasteride for hair loss in transgender women, particularly in relation to testosterone suppression. The original poster has been using dutasteride and is considering stopping it due to undetectable testosterone levels.
The user observed some regrowth and longer baby hairs after one month of using finasteride, despite experiencing increased shedding. They noted no side effects except for clear semen.
The user showed a significant improvement in hair density after four months using finasteride and minoxidil. They also used a micro needle pen, hair care like coconut oil, and improved their diet.
The conversation discusses the results of a group buy for Ky19382 related to hair loss treatments. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.
User on fin, minox, and ketoconazole seeks to add another topical anti-androgen. Hierarchy of effectiveness: 1. RU55841, 2. Fluridil - Eucapil, 3. CB-03-01 - Breezula, 4. Ketoconazole; alfatradiol suggested as addition.
Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.
User taking 1mg finasteride daily for 2 years, wants to block more scalp DHT. Seeks reference for additional topical DHT blockers like alfatradiol and fluridil.